Engaging HIV Patients in Primary Care by Promoting Acceptance
通过促进接受来让艾滋病毒患者参与初级保健
基本信息
- 批准号:8466640
- 负责人:
- 金额:$ 21.56万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-03-21 至 2016-01-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS preventionAIDS/HIV problemAdherenceAdverse effectsAftercareAnti-Retroviral AgentsAnxietyAppointments and SchedulesAttentionBehavior TherapyBehavioralCaringCase ManagerCessation of lifeClinicClinicalClinical TrialsCognitionCommunitiesCompetenceComplexConsentCounselingDevelopmentDisclosureDistressDropsEnrollmentFamilyFrequenciesFriendsFrightGoalsGuidelinesHIVHIV SeropositivityHIV diagnosisIndividualInterventionLifeLinkMeasuresMediatingMedicalModelingOutcomeParticipantPathway interactionsPatientsPerceptionPharmaceutical PreparationsPlant RootsPopulationPreparationPrimary Health CareProceduresProcessProcess AssessmentProfessional counselorPropertyPsychometricsPublic HealthQuality of lifeRandomizedRandomized Clinical TrialsResearchResearch DesignRiskSamplingSelf ManagementServicesSexual PartnersSocial supportStigmatizationStructureTechniquesTestingTherapeutic EffectTraining ProgramsTreatment EfficacyValidity and ReliabilityVisitWorkbasebrief interventioncare seekingcostexperiencefollow-upimprovedindium arsenidemedical appointmentmedication compliancenovelpilot trialprimary care settingprimary outcomepsychologicpublic health relevanceresponsesecondary outcomesocial stigmastressortransmission processtreatment as usualwillingness
项目摘要
DESCRIPTION (provided by applicant): The challenge of living with HIV involves long-term, complex self-management as well as consistent engagement in medical care. Engagement represents a patient's longitudinal commitment to care and permits People Living With HIV/AIDS (PLWHA) to take advantage of effective medical treatments. Yet too often patients new to care drop out of care or fail to maintain a regular appointment schedule. This proposal targets exploring and increasing acceptance of one's HIV status as a means to maximize engagement. Acceptance-based interventions target experiential avoidance, or an individual's attempts to avoid distressing internal and external experiences. For PLWHA, this might include anxiety about pending CD4 lab results or fear of stigmatization in one's community due to HIV diagnosis. Based on our prior work with PLWHA and acceptance-based interventions to keep patients in care in other populations, we suggest reductions in experiential avoidance will allow PLWHA to gain self-acceptance of serostatus and overcome engagement barriers. Our pilot development of a brief acceptance-based behavior therapy (ABBT) for antiretroviral adherence rooted in acceptance and commitment therapy (ACT), showed feasibility and acceptability in the primary care setting. However, this trial suggested that any improvement in medication adherence required prior engagement in medical services, the focus of the current proposal. Inevitably, life with HIV is stressful for a variety of reasons (e.g., medication side effects, shae, etc.); we suggest acceptance provides PLWHA with a framework to tolerate these stressors in the service of prioritizing a value-driven approach to engaging in medical care. The objectives of this R34 Clinical Trial Planning proposal are to (a) adapt ABBT to a two-session, individual-based acceptance-focused intervention to be delivered by case managers to diverse HIV+ primary care patients; (b) using an iterative open trial (n = 10), establish the structure, content acceptability, and feasibility of the adapted intervention; (c) conduct a randomized pilot trial ina sample of 40 ethnically/racially diverse patients who are new to primary care to establish the efficacy of ABBT in comparison to an treatment- as-usual (TAU) control condition, as preparation for an eventual large-scale (R01), adequately powered randomized clinical trial with the same research design; and, (d) examine preliminary psychometric properties of a novel measure of willingness to disclosure HIV status to non-sex partners. The clinical and public health impact of this project will be the development of a simple, low-cost, disseminable intervention for HIV patients new to care that enhances a patient's longitudinal commitment to care so s/he can obtain effective medical treatments that will prolong survival and improve quality of life.
描述(由申请人提供):艾滋病毒的生活挑战涉及长期,复杂的自我管理以及一致参与医疗服务。订婚代表了患者对护理的纵向承诺,并允许患有艾滋病毒/艾滋病的人(PLWHA)利用有效的医疗治疗。然而,新手的病人通常会辍学或无法维持定期的任命时间表。该提案针对探索并增加对自己的艾滋病毒状况的接受,以此作为最大化参与的一种手段。基于接受的干预措施针对体验避免,或者个人避免痛苦的内部和外部经历的尝试。对于PLWHA,这可能包括焦虑不安的CD4实验室结果或由于HIV诊断而害怕在社区中受到污名化。基于我们先前与PLWHA的工作和基于接受的干预措施,以使患者在其他人群中保持护理状态,我们建议减少体验式避免的情况,这将使PLWHA能够获得对血清的自我接受并克服参与障碍。 我们对基于接受和承诺疗法(ACT)的抗逆转录病毒依从性(ACT)进行简短接受行为疗法(ABBT)的试点开发在初级保健环境中显示出可行性和可接受性。但是,该试验表明,依从性的任何改善都需要事先参与医疗服务,这是当前提案的重点。不可避免地,出于多种原因(例如,药物副作用,Shae等),艾滋病毒的生活压力很大;我们建议接受为PLWHA提供一个框架,以容忍这些压力源,以优先考虑从事医疗服务的价值驱动方法。 该R34临床试验计划建议的目标是(a)将ABBT调整为两项,基于个人接受的干预措施,案例经理将向不同的HIV+初级保健患者提供; (b)使用迭代开放试验(n = 10),建立适应性干预的结构,内容可接受性和可行性; (c)进行随机试验试验INA样本,包括40种种族/种族多样的患者,这些患者是新的初级保健,与治疗 - 平常(TAU)控制条件相比,以确立ABBT的疗效,作为最终大规模(R01)的准备,并具有相同的研究设计的最终大型随机临床试验; (d)检查对非性别伴侣披露HIV状况的新颖措施的初步心理测量特性。 该项目的临床和公共卫生影响将是针对新手护理的艾滋病毒患者的简单,低成本,可忽视的干预措施的发展,从而增强了患者对护理的纵向承诺,因此他/他可以获得有效的医疗治疗,以延长生存并改善生活质量。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ethan Moitra其他文献
Ethan Moitra的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ethan Moitra', 18)}}的其他基金
Improving retention in care for persons with HIV who use substances by increasing acceptance and reducing stigma
通过提高接受度和减少耻辱来提高对使用药物的艾滋病毒感染者的护理保留率
- 批准号:
10409767 - 财政年份:2021
- 资助金额:
$ 21.56万 - 项目类别:
Improving retention in care for persons with HIV who use substances by increasing acceptance and reducing stigma
通过提高接受度和减少耻辱来提高对使用药物的艾滋病毒感染者的护理保留率
- 批准号:
10629325 - 财政年份:2021
- 资助金额:
$ 21.56万 - 项目类别:
Brief Acceptance-Based Retention Intervention for Newly Diagnosed HIV Patients
针对新诊断的艾滋病毒患者的基于接受的简短保留干预措施
- 批准号:
10531923 - 财政年份:2019
- 资助金额:
$ 21.56万 - 项目类别:
Brief Acceptance-Based Retention Intervention for Newly Diagnosed HIV Patients
针对新诊断的艾滋病毒患者的基于接受的简短保留干预措施
- 批准号:
10064643 - 财政年份:2019
- 资助金额:
$ 21.56万 - 项目类别:
Brief Acceptance-Based Retention Intervention for Newly Diagnosed HIV Patients
针对新诊断的艾滋病毒患者的基于接受的简短保留干预措施
- 批准号:
10304127 - 财政年份:2019
- 资助金额:
$ 21.56万 - 项目类别:
Brief Acceptance-Based Retention Intervention for Newly Diagnosed HIV Patients
针对新诊断的艾滋病毒患者的基于接受的简短保留干预措施
- 批准号:
9927347 - 财政年份:2019
- 资助金额:
$ 21.56万 - 项目类别:
Engaging HIV Patients in Primary Care by Promoting Acceptance
通过促进接受来让艾滋病毒患者参与初级保健
- 批准号:
8640204 - 财政年份:2013
- 资助金额:
$ 21.56万 - 项目类别:
相似海外基金
Enhancing HIV prevention and reducing alcohol use among people receiving STI care in Malawi: An HIV status neutral approach
在马拉维接受性传播感染护理的人群中加强艾滋病毒预防并减少饮酒:艾滋病毒状况中立的方法
- 批准号:
10696585 - 财政年份:2023
- 资助金额:
$ 21.56万 - 项目类别:
Yuva Sath: A peer-led intervention to support substance use treatment and HIV prevention among young people who inject drugs in India
Yuva Sath:一项由同伴主导的干预措施,旨在支持印度注射吸毒年轻人的药物滥用治疗和艾滋病毒预防
- 批准号:
10698376 - 财政年份:2023
- 资助金额:
$ 21.56万 - 项目类别:
Testing the Efficacy of Safe South Africa: An Intervention to Prevent HIV Risk and Interpersonal Violence Among Adolescent Boys
测试安全南非的功效:预防青春期男孩艾滋病毒风险和人际暴力的干预措施
- 批准号:
10700232 - 财政年份:2023
- 资助金额:
$ 21.56万 - 项目类别:
Women, Intersectionality, Substance Use and HIV ( WISH)
妇女、交叉性、药物滥用和艾滋病毒 (WISH)
- 批准号:
10484071 - 财政年份:2022
- 资助金额:
$ 21.56万 - 项目类别:
reSET for the Treatment of Stimulant Use in HIV Clinics: Care Optimization Supporting Treatment Adherence (COSTA)
用于治疗 HIV 诊所兴奋剂使用的 reSET:护理优化支持治疗依从性 (COSTA)
- 批准号:
10553554 - 财政年份:2022
- 资助金额:
$ 21.56万 - 项目类别: